Matthew Stedman的动态

?? Sign up for our July 11 webinar! Our experts Todd Rudo, Amit Vasanji, and Kelly Dumais will explore strategies to enhance patient access and precision analysis using artificial intelligence (#AI) in ophthalmology clinical trials. We’ll dive into: ??Vendor-agnostic, multi-modality platforms ??AI-enabled workflows ??Best practices for eCOA implementation in various trial settings ?? Register now and don’t miss the opportunity to learn how AI transforms ophthalmology clinical trials: https://lnkd.in/eRBrcDtQ #artificialintelligence #clinicaltrials #ophthalmology

?? Sign up for our July 11 webinar! Our experts Todd Rudo, Amit Vasanji, and Kelly Dumais will explore strategies to enhance patient access and precision analysis using artificial intelligence (#AI) in ophthalmology clinical trials. We’ll dive into: ??Vendor-agnostic, multi-modality platforms ??AI-enabled workflows ??Best practices for eCOA implementation in various trial settings ?? Register now and don’t miss the opportunity to learn how AI transforms ophthalmology clinical trials: https://lnkd.in/etkm-Xnt #artificialintelligence #clinicaltrials #ophthalmology

?? Sign up for our July 11 webinar! Our experts Todd Rudo, Amit Vasanji, and Kelly Dumais will explore strategies to enhance patient access and precision analysis using artificial intelligence (#AI) in ophthalmology clinical trials. We’ll dive into: ??Vendor-agnostic, multi-modality platforms ??AI-enabled workflows ??Best practices for eCOA implementation in various trial settings ?? Register now and don’t miss the opportunity to learn how AI transforms ophthalmology clinical trials: https://lnkd.in/dv-5-y3R #artificialintelligence #clinicaltrials #ophthalmology

Cool stuff for eCOA and Imaging in ophthalmology research! ?? Sign up for our July 11 webinar! Our experts Todd Rudo, Amit Vasanji, and Kelly Dumais will explore strategies to enhance patient access and precision analysis using artificial intelligence (#AI) in ophthalmology clinical trials. We’ll dive into: ??Vendor-agnostic, multi-modality platforms ??AI-enabled workflows ??Best practices for eCOA implementation in various trial settings ?? Register now and don’t miss the opportunity to learn how AI transforms ophthalmology clinical trials: https://lnkd.in/eYh52nv7 #artificialintelligence #clinicaltrials #ophthalmology

?? Sign up for our July 11 webinar! Our experts Todd Rudo, Amit Vasanji, and Kelly Dumais will explore strategies to enhance patient access and precision analysis using artificial intelligence (#AI) in ophthalmology clinical trials. We’ll dive into: ??Vendor-agnostic, multi-modality platforms ??AI-enabled workflows ??Best practices for eCOA implementation in various trial settings ?? Register now and don’t miss the opportunity to learn how AI transforms ophthalmology clinical trials: https://hubs.li/Q02CD4gL0 #artificialintelligence #clinicaltrials #ophthalmology

?? Sign up for our July 11 webinar! Our experts Todd Rudo, Amit Vasanji, and Kelly Dumais will explore strategies to enhance patient access and precision analysis using artificial intelligence (#AI) in ophthalmology clinical trials. We’ll dive into: ??Vendor-agnostic, multi-modality platforms ??AI-enabled workflows ??Best practices for eCOA implementation in various trial settings ?? Register now and don’t miss the opportunity to learn how AI transforms ophthalmology clinical trials: https://hubs.li/Q02CD4gL0 #artificialintelligence #clinicaltrials #ophthalmology

World Sight Day 2024: Experts weigh-in on potential impact of AI in diagnostics and screening. On World Sight Day, leading experts in ophthalmology look at artificial intelligence and how it could impact diagnosing and finding diseases in the future. Watch: https://ow.ly/1NLq50TJ2Pn

New partnership in eye care! Read our article here https://lnkd.in/gHPmNR2v to learn how Bausch + Lomb and Character Biosciences are teaming up to rewrite the playbook for age-related macular degeneration (AMD). This collaboration combines Bausch + Lomb's decades of expertise in ophthalmology with Character Bio's innovative data platform and AI-driven analytics to bring personalized therapies for AMD patients. #Ophthalmology #AMD #BauschandLomb #PIEMagazine #MediaMICE

How can we reliably detect signs of #glaucomatousdefects in real-time and make an accessible toolbox for clinicians? Turns out, advanced data analysis combined with an open-source Python-based GUI offers a solution! I am humbled to present our research at the New England Ophthalmology Society, where we propose a robust and reliable GUI to enhance the decision-making process in glaucoma defect evaluation. #glaucomatousdefect #dataanalysis

Researchers have developed ‘AIRDetect,’ a #DeepLearningModel analysing 45,749 retinal images. This #innovation accelerates diagnosis and management of inherited retinal diseases. #AI can uncover patterns in fundus autofluorescence imaging (FAF) that were previously too time-consuming to analyse. Read more: https://buff.ly/3CsZCGs William Woof, Michel Michaelides, Konstantinos Balaskas & Nikolas Pontikos UCL Institute of Ophthalmology | Moorfields Eye Hospital, London | UCL Translational Research Office (TRO) Accessible video: https://buff.ly/4jvGYPc